We've found
						6,982
						 archived clinical trials in
						Endocrine
					
				We've found
						6,982
						 archived clinical trials in
						Endocrine
	
	Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease
	
Updated: 5/26/2016
  
  
  Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease
		Status: Enrolling	
	Updated: 5/26/2016
	
	Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease
	
Updated: 5/26/2016
  
  
  	  Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease
		Status: Enrolling	
	Updated: 5/26/2016
Click here to add this to my saved trials
		    
			
	Timing Estrogen After MenoPaUSe
	
Updated: 5/31/2016
  
  
  Time Past Menopause, Duration of Estrogen Deficiency, and Insulin Action
		Status: Enrolling	
	Updated: 5/31/2016
	
	Timing Estrogen After MenoPaUSe
	
Updated: 5/31/2016
  
  
  	  Time Past Menopause, Duration of Estrogen Deficiency, and Insulin Action
		Status: Enrolling	
	Updated: 5/31/2016
Click here to add this to my saved trials
		    
			
	Peds Metabolic Syndrome in Psoriasis
	
Updated: 6/20/2016
  
  
  Assessor-Blinded Study of the Metabolic Syndrome and Surrogate Markers of Increased Cardiovascular Risk in Children With Moderate to Severe Psoriasis Compared With Age Matched Population of Children With Warts
		Status: Enrolling	
	Updated: 6/20/2016
	
	Peds Metabolic Syndrome in Psoriasis
	
Updated: 6/20/2016
  
  
  	  Assessor-Blinded Study of the Metabolic Syndrome and Surrogate Markers of Increased Cardiovascular Risk in Children With Moderate to Severe Psoriasis Compared With Age Matched Population of Children With Warts
		Status: Enrolling	
	Updated: 6/20/2016
Click here to add this to my saved trials
		    
			
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
	
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  	  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
Click here to add this to my saved trials
		    
			
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
	
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  	  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
Click here to add this to my saved trials
		    
			
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
	
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  	  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
Click here to add this to my saved trials
		    
			
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
	
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  	  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
Click here to add this to my saved trials
		    
			
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
	
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  	  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
Click here to add this to my saved trials
		    
			
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
	
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  	  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
Click here to add this to my saved trials
		    
			
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
	
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  	  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
Click here to add this to my saved trials
		    
			
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
	
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  	  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
Click here to add this to my saved trials
		    
			
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
	
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  	  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
Click here to add this to my saved trials
		    
			
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
	
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  	  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
Click here to add this to my saved trials
		    
			
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
	
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  	  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
Click here to add this to my saved trials
		    
			
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
	
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  	  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
Click here to add this to my saved trials
		    
			
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
	
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  	  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
Click here to add this to my saved trials
		    
			
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
	
	A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
	
Updated: 6/27/2016
  
  
  	  A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
		Status: Enrolling	
	Updated: 6/27/2016
Click here to add this to my saved trials
		    
			
	Male:Female Birth Ratios and Phthalate Levels
	
Updated: 7/12/2016
  
  
  Male:Female Birth Ratios and Phthalate Levels Along The Rural Lower Rio Grande Valley (Hidalgo County) and in Baytown, Texas
		Status: Enrolling	
	Updated: 7/12/2016
	
	Male:Female Birth Ratios and Phthalate Levels
	
Updated: 7/12/2016
  
  
  	  Male:Female Birth Ratios and Phthalate Levels Along The Rural Lower Rio Grande Valley (Hidalgo County) and in Baytown, Texas
		Status: Enrolling	
	Updated: 7/12/2016
Click here to add this to my saved trials
		    
			
	Male:Female Birth Ratios and Phthalate Levels
	
Updated: 7/12/2016
  
  
  Male:Female Birth Ratios and Phthalate Levels Along The Rural Lower Rio Grande Valley (Hidalgo County) and in Baytown, Texas
		Status: Enrolling	
	Updated: 7/12/2016
	
	Male:Female Birth Ratios and Phthalate Levels
	
Updated: 7/12/2016
  
  
  	  Male:Female Birth Ratios and Phthalate Levels Along The Rural Lower Rio Grande Valley (Hidalgo County) and in Baytown, Texas
		Status: Enrolling	
	Updated: 7/12/2016
Click here to add this to my saved trials
		    
			
	Male:Female Birth Ratios and Phthalate Levels
	
Updated: 7/12/2016
  
  
  Male:Female Birth Ratios and Phthalate Levels Along The Rural Lower Rio Grande Valley (Hidalgo County) and in Baytown, Texas
		Status: Enrolling	
	Updated: 7/12/2016
	
	Male:Female Birth Ratios and Phthalate Levels
	
Updated: 7/12/2016
  
  
  	  Male:Female Birth Ratios and Phthalate Levels Along The Rural Lower Rio Grande Valley (Hidalgo County) and in Baytown, Texas
		Status: Enrolling	
	Updated: 7/12/2016
Click here to add this to my saved trials
		    
			
	Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity
	
Updated: 7/14/2016
  
  
  Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity
		Status: Enrolling	
	Updated: 7/14/2016
	
	Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity
	
Updated: 7/14/2016
  
  
  	  Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity
		Status: Enrolling	
	Updated: 7/14/2016
Click here to add this to my saved trials
		    
			
	The Measurement of Insulin Resistance in Peritoneal Dialysis Patients
	
Updated: 7/18/2016
  
  
  The Measurement of Insulin Resistance in Peritoneal Dialysis Patients
		Status: Enrolling	
	Updated: 7/18/2016
	
	The Measurement of Insulin Resistance in Peritoneal Dialysis Patients
	
Updated: 7/18/2016
  
  
  	  The Measurement of Insulin Resistance in Peritoneal Dialysis Patients
		Status: Enrolling	
	Updated: 7/18/2016
Click here to add this to my saved trials
		    
			
	An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
	
Updated: 7/19/2016
  
  
  An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
		Status: Enrolling	
	Updated: 7/19/2016
	
	An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
	
Updated: 7/19/2016
  
  
  	  An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
		Status: Enrolling	
	Updated: 7/19/2016
Click here to add this to my saved trials
		    
			
	An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
	
Updated: 7/19/2016
  
  
  An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
		Status: Enrolling	
	Updated: 7/19/2016
	
	An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
	
Updated: 7/19/2016
  
  
  	  An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
		Status: Enrolling	
	Updated: 7/19/2016
Click here to add this to my saved trials
		    
			
	An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
	
Updated: 7/19/2016
  
  
  An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
		Status: Enrolling	
	Updated: 7/19/2016
	
	An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
	
Updated: 7/19/2016
  
  
  	  An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
		Status: Enrolling	
	Updated: 7/19/2016
Click here to add this to my saved trials
		    
			
	An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
	
Updated: 7/19/2016
  
  
  An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
		Status: Enrolling	
	Updated: 7/19/2016
	
	An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
	
Updated: 7/19/2016
  
  
  	  An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
		Status: Enrolling	
	Updated: 7/19/2016
Click here to add this to my saved trials
		    
			
	An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
	
Updated: 7/19/2016
  
  
  An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
		Status: Enrolling	
	Updated: 7/19/2016
	
	An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
	
Updated: 7/19/2016
  
  
  	  An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
		Status: Enrolling	
	Updated: 7/19/2016
Click here to add this to my saved trials
		    
			
	An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
	
Updated: 7/19/2016
  
  
  An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
		Status: Enrolling	
	Updated: 7/19/2016
	
	An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
	
Updated: 7/19/2016
  
  
  	  An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
		Status: Enrolling	
	Updated: 7/19/2016
Click here to add this to my saved trials
		    
			
	An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
	
Updated: 7/19/2016
  
  
  An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
		Status: Enrolling	
	Updated: 7/19/2016
	
	An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
	
Updated: 7/19/2016
  
  
  	  An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
		Status: Enrolling	
	Updated: 7/19/2016
Click here to add this to my saved trials
		    
			
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
	
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  	  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
Click here to add this to my saved trials
		    
			
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
	
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  	  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
Click here to add this to my saved trials
		    
			
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
	
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  	  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
Click here to add this to my saved trials
		    
			
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
	
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  	  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
Click here to add this to my saved trials
		    
			
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
	
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  	  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
Click here to add this to my saved trials
		    
			
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
	
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  	  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
Click here to add this to my saved trials
		    
			
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
	
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  	  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
Click here to add this to my saved trials
		    
			
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
	
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  	  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
Click here to add this to my saved trials
		    
			
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
	
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  	  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
Click here to add this to my saved trials
		    
			
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
	
	Versartis International Trial in Adults With Long-Acting Growth Hormone
	
Updated: 7/20/2016
  
  
  	  An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
		Status: Enrolling	
	Updated: 7/20/2016
Click here to add this to my saved trials
		    
			
	AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
	
Updated: 7/20/2016
  
  
  Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
		Status: Enrolling	
	Updated: 7/20/2016
	
	AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
	
Updated: 7/20/2016
  
  
  	  Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
		Status: Enrolling	
	Updated: 7/20/2016
Click here to add this to my saved trials
		    
			
	AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
	
Updated: 7/20/2016
  
  
  Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
		Status: Enrolling	
	Updated: 7/20/2016
	
	AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
	
Updated: 7/20/2016
  
  
  	  Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
		Status: Enrolling	
	Updated: 7/20/2016
Click here to add this to my saved trials
		    
			
	AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
	
Updated: 7/20/2016
  
  
  Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
		Status: Enrolling	
	Updated: 7/20/2016
	
	AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
	
Updated: 7/20/2016
  
  
  	  Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
		Status: Enrolling	
	Updated: 7/20/2016
Click here to add this to my saved trials
		    
			
	AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
	
Updated: 7/20/2016
  
  
  Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
		Status: Enrolling	
	Updated: 7/20/2016
	
	AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
	
Updated: 7/20/2016
  
  
  	  Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
		Status: Enrolling	
	Updated: 7/20/2016
Click here to add this to my saved trials
		    
			
	AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
	
Updated: 7/20/2016
  
  
  Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
		Status: Enrolling	
	Updated: 7/20/2016
	
	AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
	
Updated: 7/20/2016
  
  
  	  Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
		Status: Enrolling	
	Updated: 7/20/2016
Click here to add this to my saved trials
		    
			
	AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
	
Updated: 7/20/2016
  
  
  Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
		Status: Enrolling	
	Updated: 7/20/2016
	
	AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
	
Updated: 7/20/2016
  
  
  	  Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
		Status: Enrolling	
	Updated: 7/20/2016
Click here to add this to my saved trials
		    
			
	Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop
	
Updated: 7/28/2016
  
  
  Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop
		Status: Enrolling	
	Updated: 7/28/2016
	
	Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop
	
Updated: 7/28/2016
  
  
  	  Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop
		Status: Enrolling	
	Updated: 7/28/2016
Click here to add this to my saved trials
		    
			
	Effects of Almond Intake on Atherogenic Dyslipidemia of the Metabolic Syndrome
	
Updated: 8/1/2016
  
  
  Effects of Almond Intake on Atherogenic Dyslipidemia of the Metabolic Syndrome
		Status: Enrolling	
	Updated: 8/1/2016
	
	Effects of Almond Intake on Atherogenic Dyslipidemia of the Metabolic Syndrome
	
Updated: 8/1/2016
  
  
  	  Effects of Almond Intake on Atherogenic Dyslipidemia of the Metabolic Syndrome
		Status: Enrolling	
	Updated: 8/1/2016
Click here to add this to my saved trials
		    
			
	Continuous Glucose Monitoring and Preterm Infants
	
Updated: 8/9/2016
  
  
  NEONATAL HYPOGLYCEMIA and CONTINUOUS GLUCOSE MONITORING: A RANDOMIZED CONTROLLED TRIAL IN PRETERM INFANTS
		Status: Enrolling	
	Updated: 8/9/2016
	
	Continuous Glucose Monitoring and Preterm Infants
	
Updated: 8/9/2016
  
  
  	  NEONATAL HYPOGLYCEMIA and CONTINUOUS GLUCOSE MONITORING: A RANDOMIZED CONTROLLED TRIAL IN PRETERM INFANTS
		Status: Enrolling	
	Updated: 8/9/2016
Click here to add this to my saved trials
		    
			
	Continuous Glucose Monitoring and Preterm Infants
	
Updated: 8/9/2016
  
  
  NEONATAL HYPOGLYCEMIA and CONTINUOUS GLUCOSE MONITORING: A RANDOMIZED CONTROLLED TRIAL IN PRETERM INFANTS
		Status: Enrolling	
	Updated: 8/9/2016
	
	Continuous Glucose Monitoring and Preterm Infants
	
Updated: 8/9/2016
  
  
  	  NEONATAL HYPOGLYCEMIA and CONTINUOUS GLUCOSE MONITORING: A RANDOMIZED CONTROLLED TRIAL IN PRETERM INFANTS
		Status: Enrolling	
	Updated: 8/9/2016
Click here to add this to my saved trials
		    
			
	An Extension Study to Assess the Long-term Safety and Efficacy of Pasireotide in Patients With Acromegaly
	
Updated: 8/10/2016
  
  
  Extension to a Multi-center, Randomized, Crossover, Open Label, Dose Finding Study to Compare the Safety, Efficacy, and Pharmacokinetics/Pharmacodynamics (PK/PD) Relationship of Multiple Doses of Pasireotide (SOM230) (200, 400, and 600 μg Bid) and Doses of Open Label Sandostatin® (SMS) (100 μg Tid) in Acromegalic Patients
		Status: Enrolling	
	Updated: 8/10/2016
	
	An Extension Study to Assess the Long-term Safety and Efficacy of Pasireotide in Patients With Acromegaly
	
Updated: 8/10/2016
  
  
  	  Extension to a Multi-center, Randomized, Crossover, Open Label, Dose Finding Study to Compare the Safety, Efficacy, and Pharmacokinetics/Pharmacodynamics (PK/PD) Relationship of Multiple Doses of Pasireotide (SOM230) (200, 400, and 600 μg Bid) and Doses of Open Label Sandostatin® (SMS) (100 μg Tid) in Acromegalic Patients
		Status: Enrolling	
	Updated: 8/10/2016
Click here to add this to my saved trials